Ildong Pharmaceutical Revenue

In the year 2025, Ildong Pharmaceutical had annual revenue of 566.93B KRW, down -7.81%. Ildong Pharmaceutical had revenue of 147.02B in the quarter ending December 31, 2025, a decrease of -5.60%.

Revenue

566.93B

Revenue Growth

-7.81%

P/S Ratio

1.52

Revenue / Employee

534.34M

Employees

1,061

Market Cap

863.32B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	566.93B	-48.01B	-7.81%
Dec 31, 2024	614.94B	14.18B	2.36%
Dec 31, 2023	600.76B	-36.96B	-5.80%
Dec 31, 2022	637.71B	77.58B	13.85%
Dec 31, 2021	560.13B	-1.71B	-0.30%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Boryung	1,017.43B
Daewoong	2,068.37B
Huons Global	847.45B
JW Pharmaceutical	775.30B
Dong-A Socio Holdings	1,429.77B
DongKook Pharmaceutical	926.88B
Bukwang Pharmaceutical	200.71B
Chong Kun Dang Pharmaceutical	1,692.40B

Revenue Rankings